Work

Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: CON

Year: 2021

Type: article

Abstract: This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0002442021 and the COMMENTARY: 10.34067/KID.0004892021

Source: Kidney360

DOI: 10.34067/kid.0007152020

Authors: Abhijit V. Kshirsagar, Xiaojuan Li

Institutions: University of North Carolina at Chapel Hill, Harvard University, Harvard Pilgrim Health Care

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3187442995

FWCI:

Cites: 9

Cited by: 1

Related to: 10